The liver cancer diagnostics market is projected to reach US$ 15,951.77 million by 2028 from US$ 9,323.14 million in 2021. The market is estimated to grow at a CAGR of 8.0% during 2021 to 2028.
Liver cancer begins in the cells of the liver. Multiple kinds of cancer can form in the liver. Hepatocellular carcinoma is considered the most common liver cancer and starts in the hepatocyte. According to the American Society of Clinical Oncology (ASCO), around 80% of adult primary liver cancers are hepatocellular carcinomas. Other types of liver cancer include hepatoblastoma and intrahepatic cholangiocarcinoma. These are considered to be less common. Liver cancer diagnostics comprises techniques used for liver cancer identification and confirmation.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liver Cancer Diagnostics Market: Strategic Insights
Market Size Value in US$ 9,323.14 Million in 2021 Market Size Value by US$ 15,951.77 Million by 2028 Growth rate CAGR of 8.0% from 2021 to 2028. Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liver Cancer Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 9,323.14 Million in 2021 |
| Market Size Value by | US$ 15,951.77 Million by 2028 |
| Growth rate | CAGR of 8.0% from 2021 to 2028. |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The liver cancer diagnostics market growth is attributed to the rising prevalence of liver cancer and increasing R&D investments in the development of novel diagnostic testing. On the other hand, the high cost of technologically advanced liver cancer diagnostic solutions hinders the growth of the market.
Lucrative Regions in Liver Cancer Diagnostics Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising R&D Investments in Development of Novel Diagnostic Testing
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Rising R&D Investments in Development of Novel Diagnostic Testing
The ability to accurately diagnose liver cancer progression is critical for selecting the appropriate treatment option. Further, various companies and organizations have taken enormous initiatives to develop and implement innovative solutions for the early identification of this disease in response to the rising demand. For instance, in March 2020, Roche Holding AG's Elecsys GALAD score received the US Food and Drug Administration's breakthrough device status for the early detection of an advanced form of liver cancer. The Swiss drugmaker's calculator combines factors including age, gender, and biomarker results to detect early-stage hepatocellular carcinoma, which is the most common form of liver cancer. Further, Elecsys GALAD score is designed to support clinicians by providing them with a timely and accurate diagnosis of hepatocellular carcinoma. The research and development (R&D) expenditure in 2021 was US$ 14.65 billion and in 2020, it was US$ 13.17 billion. The R&D expenditure grew by 14% on a core basis, in F. Hoffmann-La Roche Ltd, mostly driven by late-stage investments in oncology, ophthalmology, and personalized healthcare. In 2021, the R&D investment in the diagnostic division was US$ 1,878.92 million. Similarly, In November 2019, EXACT Sciences Corporation received the Food and Drug Administration’s (FDA) breakthrough designation for its blood-based test for early detection of liver cancer. Additionally, in June 2020, National Institutes of Health (NIH) scientists developed blood tests to help improve liver cancer screening, led by researchers at the National Cancer Institute (NCI). In addition, in June 2019, CancerSEEK, a liquid biopsy test, was designed by researchers at Johns Hopkins University. The test was designed to diagnose multiple cancers, including stomach, liver, ovarian, and esophageal, at an early stage, facilitating early treatment. Therefore, the increasing R&D investments and development of diagnostic tests for the detection of liver cancer are driving the liver cancer diagnostics market.
Type-Based Insights
The global liver cancer diagnostics market, based on type, is segmented into laboratory tests, endoscopy, imaging, biopsy, and others. The market for the laboratory tests segment is further segmented into blood tests and biomarkers. The laboratory tests segment held the largest share of the market in 2021. However, the imaging segment is anticipated to register the CAGR of 8.5% in the market during the forecast period.
Liver Cancer Diagnostics Market, by Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User-Based Insights
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on end user, the global liver cancer diagnostics market is segmented into hospitals and diagnostic laboratories, academic and research institutes, and CRO laboratories. The hospitals and diagnostic laboratories segment held the largest share of the market in 2021 as the hospitals provide healthcare facilities through specialized scientific equipment. A team of trained staff is assigned to deal, investigate, and restore the problems associated with modern medical science in the hospital. Various medical research teams are constantly working on introducing innovative technologies related to the diagnostics methods and other activities in the medical field. The patients generally prefer the hospital to take liver cancer treatment due to the availability of advanced treatment options. The hospitals are the point of care for the patients. Moreover, the same segment is anticipated to register a CAGR of 8.5% in the market during the forecast period.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios to dominate the liver cancer diagnostics market share. Moreover, the market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. The liver cancer diagnostics market share is anticipated to flourish with the development of new innovative products by market players.
Company Profiles
- Abbott
- BioMerieux SA
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Koninklijke Philips N.V
- QIAGEN
- Siemens Healthineers AG
- THERMO FISHER SCIENTIFIC INC.
- GE Healthcare
- Perspectum
- Helio, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The abnormal proliferation of cells in the body is referred to as cancer. Cancer of the liver starts in the cells of the liver. The liver can develop a variety of cancers. Hepatocellular carcinoma is the most prevalent type of liver cancer, and it starts in the hepatocyte. Some liver cancers can be detected through screening in persons who are at high risk but do not have symptoms, but most liver cancers are discovered when they produce symptoms. To detect liver disease, a series of blood tests known as liver function tests and imaging studies are employed.
Key factors that are driving the growth of this market are the rising prevalence of liver cancer and rising R&D investments for the development of novel diagnostic testing are expected to boost the market growth for liver cancer diagnostics over the years.
The CAGR value of the liver cancer diagnostics market during the forecasted period of 2021-2028 is 8.0%.
The laboratory tests segment held the largest share of the market in the global liver cancer diagnostics market and held the largest market share of 39.61% in 2021.
The hospitals and diagnostic laboratories segment dominated the global liver cancer diagnostics market and accounted for the largest market share of 48.56% in 2021.
The liver cancer diagnostics market majorly consists of players such as Abbott; bioMerieux SA; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Koninklijke Philips N.V.; QIAGEN; Siemens Healthineers AG; THERMO FISHER SCIENTIFIC INC.; GE Healthcare; Perspectum; Helio, Inc amongst others.
Koninklijke Philips N.V. and Siemens Healthineers AG are the top two companies that hold huge market shares in the liver cancer diagnostics market.
The North America region secures a substantial share of the global liver cancer diagnostics market. The growth of the market in the region is attributed by the rising prevalence of liver cancer. In North America, the US is the largest market for liver cancer diagnostics. The growth of this market is primarily driven by the growing prevalence of liver cancer diseases, technological advancements and developments in the US are going to accelerate the growth of this market in this country.
The coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented problems to healthcare systems, and patients with liver cancer (LC) may have been particularly affected. COVID-19 may aggravate pre-existing chronic liver damage in HCC patients, complicating cancer treatment. Cancer patients, especially those who have just completed treatment, are at a higher risk of infection and have a poorer prognosis. The first wave of the COVID-19 epidemic had a huge influence on liver cancer patients' normal care. Patients' outcomes may have been considerably harmed as a result of changes to screening, diagnostic, and treatment algorithms. The benefits and drawbacks of the tactics used will be reported through ongoing data collecting and future analysis, assisting future decision-making. However, in the long run, as the vaccination schedule is established and the transmission rate decreases, healthcare systems will return to normal and is expected to experience increased demand for liver cancer diagnostics.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Liver Cancer Diagnostics Market – By Type
1.3.2 Global Liver Cancer Diagnostics Market – By End User
1.3.3 Global Liver Cancer Diagnostics Market – By Geography
2. Liver Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Liver Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Liver Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Cancer
5.1.2 Rising R&D Investments for the Development of Novel Diagnostic Testing
5.2 Market Restraints
5.2.1 High Cost of Technologically Advanced Liver Cancer Diagnostic Solutions
5.3 Market Opportunities
5.3.1 Increasing Demand for Point-of-Care Testing
5.4 Future Trends
5.4.1 Rising Emergence of New Technologies
5.5 Impact Analysis
6. Liver Cancer Diagnostics Market – Global Analysis
6.1 Global Liver Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 Global Liver Cancer Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Liver Cancer Diagnostics Market Analysis – By Type
7.1 Overview
7.2 Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Laboratory Tests
7.3.1 Overview
7.3.2 Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Blood Tests
7.3.2.1.1 Overview
7.3.2.1.2 Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Biomarkers
7.3.2.2.1 Overview
7.3.2.2.2 Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Endoscopy
7.4.1 Overview
7.4.2 Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging
7.5.1 Overview
7.5.2 Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Biopsy
7.6.1 Overview
7.6.2 Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Liver Cancer Diagnostics Market Analysis – By End User
8.1 Overview
8.2 Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
8.3 Hospitals and Diagnostics Laboratories
8.3.1 Overview
8.3.2 Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Academic and Research Institutes
8.4.1 Overview
8.4.2 Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 CRO Laboratories
8.5.1 Overview
8.5.2 CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
9.1 North America: Liver Cancer Diagnostics Market
9.1.1 Overview
9.1.2 North America Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.3 North America Liver Cancer Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.3.1 North America Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
9.1.4 North America Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
9.1.5 North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1.1 Overview
9.1.5.1.2 US: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1.3 US Liver Cancer Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.3.1 US Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
9.1.5.1.4 US Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
9.1.5.2 Canada: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2.1 Overview
9.1.5.2.2 Canada: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2.3 Canada Liver Cancer Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.3.1 Canada Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
9.1.5.2.4 Canada Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
9.1.5.3 Mexico: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.3.1 Overview
9.1.5.3.2 Mexico: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.3.3 Mexico Liver Cancer Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.3.1 Mexico Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
9.1.5.3.4 Mexico Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
9.2 Europe: Liver Cancer Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
9.2.3 Europe: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.2.3.1 Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.2.4 Europe: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.2.5 Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.1.1 Germany: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.1.2 Germany: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.2.5.1.2.1 Germany: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.2.5.1.3 Germany: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.2.5.2 UK: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.2.1 UK: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.2.2 UK: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.2.5.2.2.1 UK: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.2.5.2.3 UK: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.2.5.3 France: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.3.1 France: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.3.2 France: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.2.5.3.2.1 France: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.2.5.3.3 France: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.2.5.4 Spain: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.4.1 Spain: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.4.2 Spain: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.2.5.4.2.1 Spain: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.2.5.4.3 Spain: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.2.5.5 Italy: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.5.1 Italy: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.5.2 Italy: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.2.5.5.2.1 Italy: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.2.5.5.3 Italy: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.2.5.6 Rest of Europe: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.6.1 Rest of Europe: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
9.2.5.6.2 Rest of Europe: Liver Cancer Diagnostics Market, by Type, 2019–2028 (USD Million)
9.2.5.6.2.1 Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019–2028 (USD Million)
9.2.5.6.3 Rest of Europe: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.3 Asia-Pacific: Liver Cancer Diagnostics Market
9.3.1 Overview
9.3.2 Asia-Pacific: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia-Pacific: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)
9.3.3.1 Asia-Pacific: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)
9.3.4 Asia-Pacific: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)
9.3.5 Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 China: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.3 China: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)
9.3.5.1.3.1 China: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)
9.3.5.1.4 China: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)
9.3.5.2 Japan: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.1 Overview
9.3.5.2.2 Japan: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.3 Japan: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)
9.3.5.2.3.1 Japan: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019–2028 (USD Million)
9.3.5.2.4 Japan: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)
9.3.5.3 India: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.3 India: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)
9.3.5.3.3.1 India: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)
9.3.5.3.4 India: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)
9.3.5.4 South Korea: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 Overview
9.3.5.4.2 South Korea: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.3 South Korea: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)
9.3.5.4.3.1 South Korea: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)
9.3.5.4.4 South Korea: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)
9.3.5.5 Australia: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Overview
9.3.5.5.2 Australia: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.3 Australia: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)
9.3.5.5.3.1 Australia: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019–2028 (USD Million)
9.3.5.5.4 Australia: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)
9.3.5.6 Rest of Asia-Pacific: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia-Pacific: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)
9.3.5.6.3.1 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)
9.3.5.6.4 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)
9.4 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts To 2028
9.4.1 Overview
9.4.2 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.3 Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.3.1 Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.4 Middle East & Africa: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
9.4.5 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
9.4.5.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.1.1 Overview
9.4.5.1.2 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.1.3 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.5.1.3.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.5.1.4 UAE: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
9.4.5.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.2.1 Overview
9.4.5.2.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.2.3 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.5.2.3.1 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.5.2.4 Saudi Arabia: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
9.4.5.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.3.1 Overview
9.4.5.3.2 South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.3.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.5.3.3.1 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.5.3.4 South Africa: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
9.4.5.4 Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.1 Overview
9.4.5.4.2 Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.3 Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
9.4.5.4.3.1 Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
9.4.5.4.4 Rest of Middle East and Africa: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
9.5 South and Central America Liver Cancer Diagnostics Market Revenue and Forecasts To 2028
9.5.1 Overview
9.5.2 South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.3 South and Central America Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)
9.5.3.1 South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
9.5.4 South and Central America: Liver Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
9.5.5 South and Central America: Liver Cancer Diagnostics Market Share by Country – 2021 & 2028, (%)
9.5.5.1 Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
9.5.5.1.1 Overview
9.5.5.1.2 Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
9.5.5.1.3 Brazil Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)
9.5.5.1.3.1 Brazil Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
9.5.5.1.4 Brazil Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
9.5.5.2 Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
9.5.5.2.1 Overview
9.5.5.2.2 Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
9.5.5.2.3 Argentina Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)
9.5.5.2.3.1 Argentina Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
9.5.5.2.4 Argentina Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
9.5.5.3 Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.3.3 Rest of South and Central America Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)
9.5.5.3.3.1 Rest of South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
9.5.5.3.4 Rest of South and Central America Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Liver Cancer Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Liver Cancer Diagnostics Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Liver Cancer Diagnostics Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Abbott
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bioMerieux SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Koninklijke Philips N.V.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Siemens Healthineers AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 THERMO FISHER SCIENTIFIC INC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GE Healthcare
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Perspectum
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Helio, Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. US Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. US Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 6. US Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Liver Cancer Diagnostics Market, by Type-Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Liver Cancer Diagnostics Market, by Type -Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Liver Cancer Diagnostics Market, by Laboratory Tests -Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Europe Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 20280 (USD Million)
Table 14. Europe Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and forecast to 20280 (USD Million)
Table 15. Europe Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 16. Germany Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 17. Germany Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 18. Germany Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 19. UK Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 20. UK Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 21. UK Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 22. France Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 23. France Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 24. France Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 25. Spain Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 26. Spain Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 27. Spain Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 28. Italy Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 29. Italy Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 30. Italy Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 31. Rest of Europe: Liver Cancer Diagnostics Market, by Type– Revenue and forecast to 2028 (USD Million)
Table 32. Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and forecast to 2028 (USD Million)
Table 33. Rest of Europe Liver Cancer Diagnostics Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 34. Asia-Pacific Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 35. Asia-Pacific Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 36. Asia-Pacific Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 37. China Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 38. China Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 39. China Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 40. Japan Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 41. Japan Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and Forecast to 2028 (USD Million)
Table 42. Japan Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 43. India Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 44. India Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 45. India Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 46. South Korea Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 47. South Korea Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and Forecast to 2028 (USD Million)
Table 48. South Korea Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 49. Australia Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 50. Australia Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and Forecast to 2028 (USD Million)
Table 51. Australia Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia-Pacific Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 55. Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 56. Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 57. Middle East & Africa: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 59. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 60. UAE: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 61. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 62. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 63. Saudi Arabia: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 64. South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 65. South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 66. South Africa: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 68. Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
Table 69. Rest of Middle East and Africa: Liver Cancer Diagnostics Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 73. Brazil Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 74. Brazil Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 76. Argentina Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 77. Argentina Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of South and Central America Liver Cancer Diagnostics Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests – Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America Liver Cancer Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 82. Organic Developments in the Liver Cancer Diagnostics Market
Table 83. Inorganic Developments in the Liver Cancer Diagnostics Market
Table 84. Glossary of Terms
LIST OF FIGURES
Figure 1. Liver Cancer Diagnostics Market Segmentation
Figure 2. Liver Cancer Diagnostics Market Segmentation, By Region
Figure 3. Global Liver Cancer Diagnostics Market Overview
Figure 4. Laboratory Tests Segment Held Largest Share by Type in Liver Cancer Diagnostics Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Liver Cancer Diagnostics Market, By Geography (US$ Million)
Figure 7. Global Liver Cancer Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Liver Cancer Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraint Pertaining to Liver Cancer Diagnostics Market
Figure 16. Global Liver Cancer Diagnostics Market – Revenue Forecast and Analysis – 2021- 2028
Figure 17. Global Liver Cancer Diagnostics Market – By Geography Forecast and Analysis – 2021- 2028.
Figure 18. Market Positioning of Key Players in Global Liver Cancer Diagnostics Market
Figure 19. Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 20. Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
Figure 28. Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America: Liver Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 32. North America Liver Cancer Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 33. North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 34. US: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Europe: Liver Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 38. Europe Liver Cancer Diagnostics Market Revenue and forecast to 2028 (USD Million)
Figure 39. Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 40. Germany: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 41. UK: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 42. France: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 43. Spain: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 44. Italy: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 45. Rest of Europe: Liver Cancer Diagnostics Market – Revenue and forecast to 2028 (USD Million)
Figure 46. Asia-Pacific: Liver Cancer Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 47. Asia-Pacific Liver Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 49. China: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)
Figure 50. Japan: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. India: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. South Korea: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Australia: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Rest of Asia-Pacific: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Middle East & Africa Liver Cancer Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 56. Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 58. UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. South and Central America: Liver Cancer Diagnostics Market, By Key Country – Revenue (2021) (USD Million)
Figure 63. South and Central America: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
Figure 64. South and Central America: Liver Cancer Diagnostics Market Share by Country – 2021 & 2028, (%)
Figure 65. Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
Figure 66. Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
Figure 67. Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
Figure 69. Impact of COVID-19 Pandemic in European Country Markets
Figure 70. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 72. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 73. Growth Strategies in the Liver Cancer Diagnostics Market (%)
The List of Companies - Liver Cancer Diagnostic Market
- Abbott
- BioMerieux SA
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Koninklijke Philips N.V
- QIAGEN
- Siemens Healthineers AG
- THERMO FISHER SCIENTIFIC INC.
- GE Healthcare
- Perspectum
- Helio, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Liver Cancer Diagnostics Market
Apr 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)